SANTA BARBARA, Calif., Dec. 7, 2017 /PRNewswire/ -- DynaSys, a leading provider of demand & supply chain planning (DSCP) solutions, today announced that CURIUM, formerly IBA Molecular, has implemented DynaSys Cloud Demand Planning to optimize its sales forecasts. This is the first step in instituting a complete cultural turnaround for the company, establishing comprehensive planning solutions, augmenting the current S&OP (Sales & Operations Planning) process and supporting CURIUM's supply chain development. DynaSys is a division of QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB).
Headquartered in Paris, CURIUM is a leader in the field of nuclear medicine. It sells radioactive products for the diagnosis of a variety of illnesses, as well as several therapeutic medicines. CURIUM was formed by the merger of IBA Molecular and Mallinckrodt Nuclear Medicine LLC. CURIUM operates in 70 countries, generating turnover of $600 million with 1,500 employees.
Until 2016, CURIUM forecast based on information from the prior year which was then interpreted by the CURIUM teams. This process may suffice in a business area considered to be "stable," but falls short of optimizing a company's supply chain. "We needed the ability to keep up with subtle differences in behavior or changes in the market," said Nicolas Gruel, CURIUM's central demand manager. Radioactive products are costly and with delivery lead times averaging two months, CURIUM was determined to ensure reliable procurement management. That determination led to the company's decision to implement a sales forecast solution. CURIUM chose a cloud-based solution to prevent overloading the existing infrastructure, enabling CURIUM to focus its efforts on its core business and not on its IT systems.
"We were looking for an agile solution tailored to our needs, and cloud-based with comprehensive functional coverage," added Gruel. "After researching the providers in the marketplace, there were only two solutions that really met our specifications. We chose DynaSys because of its proven, flexible and robust technology, its expertise in our industry, its experience with the cloud, and its all-encompassing support in setting up our project."
The DynaSys solution has been implemented in all former IBA Molecular entities and will soon be set up in all CURIUM group facilities. "Not only does DynaSys provide us with indispensable input for our sales forecasts, the collaborative aspect of demand planning is essential for us to be responsive as a global organization," added Gruel.
Despite DynaSys Cloud Demand Planning only being in place for two months, CURIUM has already received several benefits:
- Optimized structuring of in-house processes based on sales forecasts via demand planning
- Training of forecasting specialists to refine and escalate information, and the addition of a central forecaster handling international activity and the wider distributor network
- Increased medium and long-term visibility helping to anticipate production capacities and procurement requirements
- Reliable statistics for radioactive products
- Improved collaboration between facilities
- Optimized network infrastructure management
- Business processes have been structured to match the CURIUM S&OP approach
"Tomorrow, we will go even further," said Gruel. "We expect a return on investment in less than one year. As soon as demand planning is standardized across the group, we will look at how to improve our procurement processes. Finally, the major effort from now on will be the implementation of our S&OP process, which will be a significant aid to support our growth."
CURIUM is a world-class nuclear medicine solutions provider with over 100 years of industry experience. Formed through the union of IBA Molecular and Mallinckrodt Nuclear Medicine LLC, CURIUM has one of the largest vertically integrated radiopharmaceutical manufacturing networks in the industry.
With manufacturing sites in Europe and United States, CURIUM services over 14 million patients worldwide with SPECT, PET and therapeutic radiopharmaceuticals to provide potential vital diagnostics. The brand CURIUM is inspired by the radiation scientists Marie and Pierre Curie and is focused on nuclear medicine. Learn more, visit www.curiumpharma.com.
About DynaSys – Effective Enterprise Demand and Supply Chain Planning
DynaSys, a division of QAD Inc., provides Demand and Supply Chain Planning solutions. With 30 years of experience, DynaSys provides an integrated and collaborative planning solution that allows businesses to optimize their supply chains. The DynaSys suite includes sales and operations planning, demand planning and network, inventory and business resources. DynaSys software enables customers and partners in the consumer goods, life sciences, food and beverage, high tech, automotive, distribution and wholesale verticals to meet their goals of better managing Demand and Supply Chain Planning, and becoming more Effective Enterprises.
About QAD – The Effective Enterprise
QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB) is a leading provider of enterprise software and services designed for global manufacturing companies. For more than 35 years, QAD has provided global manufacturing companies with QAD Enterprise Applications, an enterprise resource planning (ERP) system that supports operational requirements, including financials, manufacturing, demand and supply chain planning, customer management, business intelligence and business process management. QAD Enterprise Applications is offered in flexible deployment models in the cloud, on-premise or in a blended environment. With QAD, customers and partners in the automotive, consumer products, food and beverage, high technology, industrial products and life sciences industries can better align daily operations with their strategic goals to meet their vision of becoming more Effective Enterprises.
For more information about QAD, call +1 805-566-6000, visit www.qad.com.
"QAD" is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.
Note to Investors: This press release contains certain forward-looking statements made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding projections of revenue, income and loss, capital expenditures, plans and objectives of management regarding the Company's business, future economic performance or any of the assumptions underlying or relating to any of the foregoing. Forward-looking statements are based on the company's current expectations. Words such as "expects," "believes," "anticipates," "could," "will likely result," "estimates," "intends," "may," "projects," "should," "would," "might," "plan" and variations of these words and similar expressions are intended to identify these forward-looking statements. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to: risks associated with our cloud service offerings, such as defects and disruptions in our services, our ability to properly manage our cloud service offerings, our reliance on third-party hosting and other service providers, and our exposure to liability and loss from security breaches; demand for the company's products, including cloud service, licenses, services and maintenance; pressure to make concessions on our pricing and changes in our pricing models; protection of our intellectual property; dependence on third-party suppliers and other third-party relationships, such as sales, services and marketing channels; changes in our revenue, earnings, operating expenses and margins; the reliability of our financial forecasts and estimates of the costs and benefits of transactions; the ability to leverage changes in technology; defects in our software products and services; third-party opinions about the company; competition in our industry; the ability to recruit and retain key personnel; delays in sales; timely and effective integration of newly acquired businesses; economic conditions in our vertical markets and worldwide; exchange rate fluctuations; and the global political environment. For a more detailed description of the risk factors associated with the company and factors that may affect our forward-looking statements, please refer to the company's latest Annual Report on Form 10-K and, in particular, the section entitled "Risk Factors" therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. Management does not undertake to update these forward-looking statements except as required by law.
03 88 19 42 33 / 06 09 01 82 56
01 30 64 14 20 / 06 08 25 27 74
Evan Quinn, 617-869-7335
Scott Matulis, 818-451-8918